ELEVANCE HEALTH, INC. (ELV) Operating Margin
- Operating margin · 12 months: Value 2.71%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 2.71% | Operating income / revenue. Period ending 2026-06-30. $5.45B ÷ $201.11B × 100 ≈ 2.71% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 5.45B USD | Operating Income (Loss) |
| Revenue | 201.11B USD | |
| Cost of products and services | 21.86B USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | 22.56B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5.45B | $201.11B | $21.86B | (m) | $22.56B | 2.71% |
| 2026-03-31 | $6.12B | $200.41B | $21.66B | (m) | $22.01B | 3.05% |
| 2025-12-31 | $7.20B | $199.13B | $21.18B | (m) | $20.98B | 3.62% |
| 2025-09-30 | $7.56B | $194.82B | $21.67B | (m) | $20.37B | 3.88% |
| 2025-06-30 | $7.68B | $189.22B | $21.38B | (m) | $20.37B | 4.06% |
| 2025-03-31 | $8.02B | $183.32B | $20.91B | (m) | $20.44B | 4.37% |
| 2024-12-31 | $7.86B | $177.01B | $19.75B | (m) | $20.02B | 4.44% |
| 2024-09-30 | $8.47B | $174.22B | $18.57B | (m) | $20.22B | 4.86% |
| 2024-06-30 | $8.82B | $171.96B | $18.13B | (m) | $20.42B | 5.13% |
| 2024-03-31 | $8.68B | $171.75B | $17.64B | (m) | $20.17B | 5.06% |
| 2023-12-31 | $8.50B | $171.34B | $17.29B | (m) | $20.09B | 4.96% |
| 2023-09-30 | $8.47B | $168.62B | $16.10B | (m) | $19.66B | 5.03% |
| 2023-06-30 | $9.14B | $165.71B | $14.89B | (m) | $18.69B | 5.51% |
| 2023-03-31 | $8.86B | $160.67B | $13.63B | (m) | $18.14B | 5.51% |
| 2022-12-31 | $8.45B | $156.59B | $13.04B | (m) | $17.69B | 5.40% |
| 2022-09-30 | $8.27B | $153.25B | $12.46B | (m) | $17.35B | 5.40% |
| 2022-06-30 | $8.06B | $149.13B | $11.92B | (m) | $16.78B | 5.41% |
| 2022-03-31 | $7.78B | $144.35B | $11.46B | (m) | $16.33B | 5.39% |
| 2021-12-31 | $7.49B | $138.64B | $10.89B | (m) | $15.91B | 5.40% |
| 2021-09-30 | $6.91B | $133.88B | $10.35B | (m) | $16.01B | 5.16% |
| 2021-06-30 | $5.05B | $129.22B | $9.67B | (m) | $17.37B | 3.91% |
| 2021-03-31 | $6.33B | $124.63B | $9.28B | (m) | $17.59B | 5.08% |
| 2020-12-31 | $6.36B | $121.87B | $8.95B | (m) | $17.45B | 5.22% |
| 2020-09-30 | $6.85B | $117.45B | $7.58B | (m) | $16.63B | 5.83% |
| 2020-06-30 | $8.18B | $112.97B | $6.10B | (m) | $14.75B | 7.24% |
| 2020-03-31 | $6.25B | $109.17B | $3.98B | (m) | $13.98B | 5.73% |
| 2019-12-31 | $6.00B | $104.21B | $1.99B | (m) | $13.36B | 5.76% |
| 2019-09-30 | $5.65B | $100.18B | (m) | (m) | $13.48B | 5.64% |
| 2019-06-30 | $5.37B | $96.76B | (m) | (m) | $13.61B | 5.55% |
| 2019-03-31 | $5.50B | $94.23B | (m) | (m) | $13.76B | 5.83% |
| 2018-12-31 | $5.43B | $92.11B | (m) | (m) | $14.02B | 5.89% |
| 2018-09-30 | $5.06B | $91.41B | (m) | (m) | $13.80B | 5.53% |
| 2018-06-30 | $4.79B | $90.59B | (m) | (m) | $13.26B | 5.29% |
| 2018-03-31 | $4.46B | $90.05B | (m) | (m) | $12.89B | 4.95% |
| 2017-12-31 | $4.18B | $90.04B | (m) | (m) | $12.65B | 4.64% |
| 2017-09-30 | $4.45B | $89.07B | (m) | (m) | $12.52B | 4.99% |
| 2017-06-30 | $4.54B | $88.05B | (m) | (m) | $12.63B | 5.16% |
| 2017-03-31 | $4.82B | $87.10B | (m) | (m) | $12.55B | 5.53% |
| 2016-12-31 | $4.80B | $84.86B | (m) | (m) | $12.56B | 5.66% |
| 2016-09-30 | $4.59B | $83.34B | (m) | (m) | $12.56B | 5.51% |
| 2016-06-30 | $4.73B | $81.83B | (m) | (m) | $12.52B | 5.78% |
| 2016-03-31 | $4.74B | $80.39B | (m) | (m) | $12.59B | 5.90% |
| 2015-12-31 | $4.75B | $79.16B | (m) | (m) | $12.53B | 6.00% |
| 2015-09-30 | $5.20B | $77.95B | (m) | (m) | $12.30B | 6.67% |
| 2015-06-30 | $5.17B | $76.61B | (m) | (m) | $12.19B | 6.75% |
| 2015-03-31 | $4.88B | $75.07B | (m) | (m) | $12.03B | 6.50% |
| 2014-12-31 | $4.42B | $73.87B | (m) | (m) | $11.75B | 5.98% |
| 2014-09-30 | $3.95B | $72.79B | (m) | (m) | $11.36B | 5.43% |
| 2014-06-30 | $3.76B | $72.09B | (m) | (m) | $10.94B | 5.22% |
| 2014-03-31 | $3.76B | $71.31B | (m) | (m) | $10.49B | 5.28% |
| 2013-12-31 | $4.00B | $71.02B | (m) | (m) | $9.95B | 5.63% |
| 2013-09-30 | $4.04B | $68.99B | (m) | (m) | $9.83B | 5.86% |
| 2013-06-30 | $4.03B | $66.37B | (m) | (m) | $9.33B | 6.08% |
| 2013-03-31 | $3.79B | $63.98B | (m) | (m) | $8.94B | 5.93% |
| 2012-12-31 | $3.64B | $61.71B | (m) | (m) | $8.74B | 5.90% |
| 2012-09-30 | $3.72B | $61.49B | (m) | (m) | $8.55B | 6.05% |
| 2012-06-30 | $3.69B | $61.54B | (m) | (m) | $8.60B | 6.00% |
| 2012-03-31 | $3.64B | $61.23B | (m) | (m) | $8.52B | 5.95% |
| 2011-12-31 | $3.78B | $60.71B | (m) | (m) | $8.44B | 6.23% |
| 2011-09-30 | $3.96B | $60.12B | (m) | (m) | $8.65B | 6.59% |
| 2011-06-30 | $4.03B | $59.29B | (m) | (m) | $8.60B | 6.80% |
| 2011-03-31 | $4.14B | $58.62B | (m) | (m) | $8.74B | 7.06% |
| 2010-12-31 | $4.08B | $58.80B | (m) | (m) | $8.84B | 6.93% |
| 2010-09-30 | (m) | $63.20B | (m) | (m) | $9.44B | (m) |
| 2010-06-30 | (m) | $64.03B | (m) | (m) | $9.61B | (m) |
| 2010-03-31 | (m) | $64.98B | (m) | (m) | $9.63B | (m) |
| 2009-12-31 | (m) | $65.03B | (m) | (m) | $9.66B | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $61.25B | (m) | (m) | $9.02B | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | $61.17B | (m) | (m) | $8.70B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |